Skip to main content

Global Thrombectomy Devices Market to Witness 6–8% CAGR Rise, Fueled by Medical Tech by 2029

 


The global thrombectomy devices market is projected to grow at a CAGR of 6-8% from 2024 to 2029. This growth is primarily driven by an increasing prevalence of stroke and cardiovascular diseases, demand for minimally invasive procedures, and technological advancements in thrombectomy devices. Expansion in emerging markets, combined with an aging population prone to vascular diseases, is expected to further propel market growth. 

The thrombectomy devices market focuses on devices used to remove clots from blood vessels to restore normal blood flow, critical in treating stroke and heart attack patients. This market includes diverse thrombectomy techniques such as aspiration, mechanical, and rheolytic, providing options for minimally invasive clot retrieval. Innovations like aspiration catheter systems with improved clot removal efficiency and stent retriever advancements support detailed, effective vascular treatment across hospitals and specialized clinics globally.

Download a free sample report now 👉
https://meditechinsights.com/global-thrombectomy-devices-market/request-sample/

Rising Demand for Thrombectomy in Stroke and Cardiovascular Procedures

The rise in the global burden of stroke and cardiovascular conditions drives the thrombectomy devices market. Real-time, minimally invasive thrombectomy procedures provide better outcomes and recovery times. Cardiovascular diseases accounts for approximately one third of all global deaths, with ischemic stroke as a leading cause. National initiatives such as the "Billion Hearts" program in the U.S. and substantial R&D investments in stroke care underscore the ongoing need for effective treatment tools like thrombectomy. Technological advancements, such as next-generation aspiration catheters and stent retrievers, support more precise clot removal, fueling the market growth.

Technological Advancements to Drive Thrombectomy Devices Market Growth

Technological advancements are driving the growth of the thrombectomy devices market, as companies introduce innovative devices that improve safety, efficiency, and clinical outcomes. For instance, Penumbra Inc. launched the Lightning Flash system in 2023, integrating intelligent aspiration technology that uses pressure and flow-based algorithms to detect and remove large clots, especially for deep vein thrombosis and pulmonary embolism cases​.  Inari Medical followed suit in 2023 with the RevCore catheter, specifically designed for venous in-stent thrombosis, alongside the Triever16 Curve, which enhances precision for both pulmonary embolism and peripheral thrombectomy treatments​. These product launches highlight the industry’s focus on developing versatile and advanced solutions, fueling adoption across vascular and neurological applications.

Competitive Landscape Analysis

In the competitive landscape of the thrombectomy devices market, several prominent players drive innovation and market expansion through strategic investments, partnerships, and technological advancements. Key companies include Medtronic; Boston Scientific; Stryker Corporation; Penumbra Inc.; Edwards Lifesciences; Abbott Laboratories; Terumo Corporation; AngioDynamics, Inc.; Spectranetics Corporation; and Inari Medical; among others. These firms focus on improving device efficacy, expanding product offerings, and forming partnerships to broaden their portfolios and global reach.

Download a sample report for in-depth competitive insights
https://meditechinsights.com/global-thrombectomy-devices-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global thrombectomy devices market at the regional- and country-level from 2022 to 2029. The report further segments the market based on device type, application, and end user.

  • Market Size & Forecast (2022-2029), By Device Type, USD Billion
    • Mechanical/Fragmentation Thrombectomy Devices
    • Aspiration Thrombectomy Devices
    • Rheolytic/Hydrodynamic Thrombectomy Devices
    • Ultrasound-assisted Thrombectomy Devices
    • Others
  • Market Size & Forecast (2022-2029), By Application, USD Billion
    • Neurovascular Thrombectomy
    • Cardiovascular Thrombectomy
    • Peripheral Thrombectomy
  • Market Size & Forecast (2022-2029), By End User, USD Billion
    • Hospitals and Health Systems
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Market Size & Forecast (2022-2029), By Region, USD Billion
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more